Search

everythinglearnresearchcommunity

for

Search:↓

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Biorregulatory therapy significantly improved the dog's health, reversing previous issues and eliminating the need for ongoing medication.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Sorafenib can cause a unique skin reaction.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Tofacitinib taken by mouth helps treat hair loss in children.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Doxorubicin causes heart damage, so early detection and monitoring are important during chemotherapy.